Related Experiment Video
Updated: Jan 15, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
The need to fast-track a change in the nomenclature of the monkeypox virus
Asukwo E Onukak1, Micah S Otu2, Juliet I Mmerem3
1Department of Internal Medicine, Faculty of Clinical Sciences, University of Uyo, Uyo, Nigeria.
Abstract:
The nomenclature of monkeypox disease has been changed to mpox, and the clades of the causative virus have also been changed in keeping with international best practices. We commend the World Health Organization for its efforts in this regard while drawing attention to the need for a change in the name of the monkeypox virus. The continual use of the viral nomenclature can be considered stigmatising, discriminatory and inaccurate.
More Related Videos
10:48Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
Published on: May 15, 2014
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Related Concept Videos
Drug Nomenclature
Viral Mutations